p.77 抽出テキスト

91. Alexis SL, Malik AH, George I, Hahn RT, Khalique OK, Seetharam K, et al. Infective endocarditis after surgical and transcatheter aortic valve replacement: a state of the art review. J Am Heart Assoc 2020;9:e017347. https://doi.org/10.1161/JAHA.120. 017347 92. Lehner A, Haas NA, Dietl M, Jakob A, Schulze-Neick I, Dalla Pozza R, et al. The risk of infective endocarditis following interventional pulmonary valve implantation: a meta-analysis. J Cardiol 2019;74:197–205. https://doi.org/10.1016/j.jjcc.2019.04.007 93. McElhinney DB, Sondergaard L, Armstrong AK, Bergersen L, Padera RF, Balzer DT, et al. Endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol 2018;72:2717–2728. https://doi.org/10.1016/j.jacc.2018.09.039 94. Summers MR, Leon MB, Smith CR, Kodali SK, Thourani VH, Herrmann HC, et al. Prosthetic valve endocarditis after TAVR and SAVR: insights from the PARTNER trials. Circulation 2019;140:1984–1994. https://doi.org/10.1161/CIRCULATIONAHA.119. 041399 95. Asmarats L, Rodriguez-Gabella T, Chamandi C, Bernier M, Beaudoin J, O’Connor K, et al. Infective endocarditis following transcatheter edge-to-edge mitral valve repair: a systematic review. Catheter Cardiovasc Interv 2018;92:583–591. https://doi.org/10. 1002/ccd.27632 96. Diller GP, Baumgartner H. Endocarditis in adults with congenital heart disease: new answers–new questions. Eur Heart J 2017;38:2057–2059. https://doi.org/10.1093/ eurheartj/ehx044 97. Ly R, Compain F, Gaye B, Pontnau F, Bouchard M, Mainardi JL, et al. Predictive factors of death associated with infective endocarditis in adult patients with congenital heart disease. Eur Heart J Acute Cardiovasc Care 2020. https://doi.org/10.1177/ 2048872620901394 98. Snygg-Martin U, Giang KW, Dellborg M, Robertson J, Mandalenakis Z. Cumulative incidence of infective endocarditis in patients with congenital heart disease: a nationwide, case-control study over nine decades. Clin Infect Dis 2021;73:1469–1475. https://doi. org/10.1093/cid/ciab478 99. Mylotte D, Rushani D, Therrien J, Guo L, Liu A, Guo K, et al. Incidence, predictors, and mortality of infective endocarditis in adults with congenital heart disease without prosthetic valves. Am J Cardiol 2017;120:2278–2283. https://doi.org/10.1016/j.amjcard. 2017.08.051 100. Mandalenakis Z, Rosengren A, Skoglund K, Lappas G, Eriksson P, Dellborg M. Survivorship in children and young adults with congenital heart disease in Sweden. JAMA Intern Med 2017;177:224–230. https://doi.org/10.1001/jamainternmed.2016. 7765 101. Rushani D, Kaufman JS, Ionescu-Ittu R, Mackie AS, Pilote L, Therrien J, et al. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation 2013;128:1412–1419. https://doi.org/10.1161/CIRCULATIONAHA. 113.001827 102. Patel S, Rizvi SSA, Choi JH, Horan DP, Weber MP, Maynes EJ, et al. Management and outcomes of left ventricular assist device-associated endocarditis: a systematic review. Ann Cardiothorac Surg 2019;8:600–609. https://doi.org/10.21037/acs.2019.04.04 103. Ostergaard L, Valeur N, Wang A, Bundgaard H, Aslam M, Gislason G, et al. Incidence of infective endocarditis in patients considered at moderate risk. Eur Heart J 2019;40: 1355–1361. https://doi.org/10.1093/eurheartj/ehy629 104. Russell EA, Walsh WF, Costello B, McLellan AJA, Brown A, Reid CM, et al. Medical management of rheumatic heart disease: a systematic review of the evidence. Cardiol Rev 2018;26:187–195. https://doi.org/10.1097/CRD.0000000000000185 105. Jordan AM, Tatum R, Ahmad D, Patel SV, Maynes EJ, Weber MP, et al. Infective endocarditis following heart transplantation: a systematic review. Transplant Rev (Orlando) 2021;36:100672. https://doi.org/10.1016/j.trre.2021.100672 106. Chuang S, Shrestha NK, Brizendine KD. Matched retrospective study of infective endocarditis among solid organ transplant recipients compared to non-transplant: seven-year experience in a US referral center. Transpl Infect Dis 2020;22:e13368. https://doi.org/10.1111/tid.13368 107. Martinez-Selles M, Valerio-Minero M, Farinas MC, Rodriguez-Abella H, Rodriguez ML, de Alarcon A, et al. Infective endocarditis in patients with solid organ transplantation. A nationwide descriptive study. Eur J Intern Med 2021;87:59–65. https://doi.org/10.1016/ j.ejim.2021.02.017 108. Duval X, Alla F, Hoen B, Danielou F, Larrieu S, Delahaye F, et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 2006;42:e102–e107. https:// doi.org/10.1086/504385 109. Findler M, Chackartchi T, Regev E. Dental implants in patients at high risk for infective endocarditis: a preliminary study. Int J Oral Maxillofac Surg 2014;43:1282–1285. https:// doi.org/10.1016/j.ijom.2014.04.015 110. Thornhill MH, Dayer M, Lockhart PB, Prendergast B. Antibiotic prophylaxis of infective endocarditis. Curr Infect Dis Rep 2017;19:9. https://doi.org/10.1007/s11908-017-0564y 111. Thornhill MH, Dayer MJ, Durkin MJ, Lockhart PB, Baddour LM. Risk of adverse reactions to oral antibiotics prescribed by dentists. J Dent Res 2019;98:1081–1087. https:// doi.org/10.1177/0022034519863645 112. Thornhill MH, Dayer MJ, Prendergast B, Baddour LM, Jones S, Lockhart PB. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother 2015;70:2382–2388. https://doi.org/10.1093/jac/dkv115 113. Verhoeven PO, Gagnaire J, Botelho-Nevers E, Grattard F, Carricajo A, Lucht F, et al. Detection and clinical relevance of Staphylococcus aureus nasal carriage: an update. Expert Rev Anti Infect Ther 2014;12:75–89. https://doi.org/10.1586/14787210.2014. 859985 114. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362:9–17. https://doi.org/10.1056/ NEJMoa0808939 115. Friedman AJ, Cosby R, Boyko S, Hatton-Bauer J, Turnbull G. Effective teaching strategies and methods of delivery for patient education: a systematic review and practice guideline recommendations. J Cancer Educ 2011;26:12–21. https://doi.org/10.1007/ s13187-010-0183-x 116. de Oliveira JC, Martinelli M, Nishioka SA, Varejao T, Uipe D, Pedrosa AA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverterdefibrillators: results of a large, prospective, randomized, double-blinded, placebocontrolled trial. Circ Arrhythm Electrophysiol 2009;2:29–34. https://doi.org/10.1161/ CIRCEP.108.795906 117. Mounsey JP, Griffith MJ, Tynan M, Gould FK, MacDermott AF, Gold RG, et al. Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J 1994;72:339–343. https://doi.org/10.1136/hrt.72.4.339 118. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015;17: 767–777. https://doi.org/10.1093/europace/euv053 119. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010;362:18–26. https://doi.org/10.1056/NEJMoa0810988 120. Lador A, Nasir H, Mansur N, Sharoni E, Biderman P, Leibovici L, et al. Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J Antimicrob Chemother 2012;67:541–550. https://doi.org/10.1093/jac/dkr470 121. Conen A, Stortecky S, Moreillon P, Hannan MM, Franzeck FC, Jeger R, et al. A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation. EuroIntervention 2021;16:1135–1140. https://doi. org/10.4244/EIJ-D-19-00993 122. Botelho-Nevers E, Thuny F, Casalta JP, Richet H, Gouriet F, Collart F, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009;169:1290–1298. https://doi.org/10.1001/ archinternmed.2009.192 123. Carrasco-Chinchilla F, Sanchez-Espin G, Ruiz-Morales J, Rodriguez-Bailon I, Melero-Tejedor JM, Ivanova-Georgieva R, et al. Influence of a multidisciplinary alert strategy on mortality due to left-sided infective endocarditis. Rev Esp Cardiol (Engl Ed) 2014;67:380–386. https://doi.org/10.1016/j.recesp.2013.09.012 124. Cervera C, del Rio A, Garcia L, Sala M, Almela M, Moreno A, et al. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Enferm Infecc Microbiol Clin 2011;29:587–592. https://doi.org/10.1016/j.eimc. 2011.05.007 125. Chirillo F, Scotton P, Rocco F, Rigoli R, Borsatto F, Pedrocco A, et al. Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol 2013;112:1171–1176. https://doi.org/10.1016/j.amjcard. 2013.05.060 126. Okura T, Iwata K, Koyama T, Ebisawa K, Arakawa Y, Kusuki M, et al. Impact of infectious disease consultation on management and outcomes of infective endocarditis. Ann Thorac Surg 2021;112:1228–1234. https://doi.org/10.1016/j.athoracsur.2020.09.044 127. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:e72–e227. https:// doi.org/10.1161/CIR.0000000000000923 128. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/ EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43: 561–632. https://doi.org/10.1093/eurheartj/ehab395 129. Wang TKM, Sanchez-Nadales A, Igbinomwanhia E, Cremer P, Griffin B, Xu B. Diagnosis of infective endocarditis by subtype using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: a contemporary meta-analysis. Circ Cardiovasc Imaging 2020;13:e010600. https://doi.org/10.1161/CIRCIMAGING. 120.010600 130. Blomstrom-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections–endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026